Irreversible Electroporation for Prostate Cancer

Area of Science:

• Oncology
• Urology
• Medical Technology

Background:

• Localized prostate cancer is treatable, but traditional radical prostatectomy (RP) and radiotherapy (RT) carry significant side effect risks.
• Focal therapy offers a promising alternative to preserve function and reduce adverse effects.
• Irreversible electroporation (IRE) is an emerging focal therapy using electrical currents for tissue ablation.

Purpose of the Study:

• To evaluate the safety and efficacy of irreversible electroporation (IRE) as a focal therapy for localized prostate cancer.
• To compare oncological and functional outcomes of IRE with traditional treatments.
• To identify the need for further clinical trials on IRE for prostate cancer.

Main Methods:

• Review of current research on irreversible electroporation (IRE) for prostate cancer treatment.
• Analysis of safety, oncological outcomes, and functional outcomes from early-stage studies.
• Assessment of IRE's potential as a focal therapy modality.

Main Results:

• Irreversible electroporation (IRE) is demonstrated as a safe procedure for localized prostate cancer.
• Good short-term oncological outcomes have been observed with IRE.
• IRE shows a lower risk of adverse functional outcomes compared to traditional treatments.

Conclusions:

• Irreversible electroporation (IRE) is a potentially effective focal therapy for localized prostate cancer.
• IRE offers a favorable risk-benefit profile, balancing oncological control with functional preservation.
• Well-designed clinical trials are warranted to definitively establish the efficacy of IRE in treating localized prostate cancer.